Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (unaudited)

v3.19.2
Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Statement of Comprehensive Income [Abstract]        
Revenue $ 4 $ 26 $ 5 $ 38
Cost of revenue 2 41 3 56
Gross profit (loss) 2 (15) 2 (18)
Operating expenses:        
Research and development 2,129 1,384 4,533 2,587
Sales and marketing 1,156 989 2,313 1,730
General and administrative 2,364 1,741 5,161 3,876
Total operating expenses 5,649 4,114 12,007 8,193
Operating loss (5,647) (4,129) (12,005) (8,211)
Warrant expense (3,156)
Loss from change in fair value of contingent royalty obligation (86) (81) (59) (159)
Finance income, net 59 30 119 29
Foreign currency loss (7) (17) (9) (23)
Loss before income taxes (5,681) (4,197) (11,954) (11,520)
Income tax expense
Net loss $ (5,681) $ (4,197) $ (11,954) $ (11,520)
Basic and diluted loss per common share (in dollars per share) $ (0.26) $ (0.27) $ (0.56) $ (0.8)
Weighted average number of common shares outstanding, basic and diluted (in shares) 21,450,877 15,645,755 21,447,218 14,318,272